Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of ...
Market expansion in med derm cross over: Almirall’s Seysara (sarecycline) won NMPA approval for moderate to severe acne (≥9 years), with China commercial launch targeted for 2026 – relevant to ...
Modern businesses rarely operate in isolation. Internal and external collaboration is crucial for growth and innovation. However, greater ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results